{"schema_version":"1","generated_at":"2026-10-30T23:17:50.592Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lawrence-singerman","json_url":"https://www.findmykol.com/kol/lawrence-singerman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lawrence-singerman","name":"Lawrence Singerman","credential":"MD","specialty":"Ophthalmology","specialty_raw":"Ophthalmology","therapeutic_area":"Ophthalmology","therapeutic_areas":["Ophthalmology"],"city":"Beachwood","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1780678029","orcid":"0000-0002-9048-8358","openalex":"A5005076098"},"summary":"Lawrence Singerman is an Ophthalmology physician. OpenAlex indexes 136 publications with 8,786 citations (h-index 37); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Ophthalmology"]},"scholarship":{"works_count":136,"cited_by_count":8786,"h_index":37,"latest_activity_year":2025,"emerging":true,"citation_standing":{"top_percent":10,"cohort":"Ophthalmology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01011374","title":"Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion","phase":"PHASE1","status":"UNKNOWN","role":"Overall official","sponsor":"Retina Associates of Cleveland, Inc","source_url":"https://clinicaltrials.gov/study/NCT01011374","trial_url":"https://www.findmykol.com/trial/NCT01011374"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":36,"shown":3,"withheld":33,"rows":[{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":254.64,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1780678029"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":196.33,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1780678029"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":184.01,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1780678029"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1780678029","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":57.8,"classes_total":2,"classes":[{"class":"Complement Inhibitor","setting":"administered","share_pct":53.9,"drugs":[{"name":"Pegcetacoplan","share_pct":100}],"max_beneficiaries":68},{"class":"Vascular Endothelial Growth Factor Inhibitor","setting":"administered","share_pct":3.9,"drugs":[{"name":"Aflibercept","share_pct":100}],"max_beneficiaries":91}]},{"area":"Sensory organs","share_pct":41.5,"classes_total":5,"classes":[{"class":"Antineovascularisation agents","setting":"administered","share_pct":40.6,"drugs":[{"name":"Faricimab-svoa","share_pct":100}],"max_beneficiaries":17},{"class":"Corticosteroid","setting":"prescribed","share_pct":0.4,"drugs":[{"name":"Prednisolone Acetate","share_pct":100}],"max_beneficiaries":26}]},{"area":"Musculoskeletal","share_pct":0.4,"classes_total":1,"classes":[{"class":"Cyclooxygenase Inhibitor","setting":"prescribed","share_pct":0.4,"drugs":[{"name":"Ketorolac Tromethamine","share_pct":100}],"max_beneficiaries":22}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":4,"fiscal_years":{"first":1985,"last":1993},"rows_total":16,"shown":3,"withheld":13,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"U10EY002554","title":"MACULAR PHOTOCOAGULATION STUDY","fiscal_year":1993,"organization":"ST. LUKE'S MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/U10EY002554"},{"project":"U10EY007788","title":"CENTRAL VEIN OCCLUSION STUDY-- PARTICIPATING CENTER","fiscal_year":1993,"organization":"MOUNT SINAI MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/U10EY007788"},{"project":"U10EY002554","title":"MACULAR PHOTOCOAGULATION STUDY","fiscal_year":1992,"organization":"ST. LUKE'S MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/U10EY002554"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"TENAYA and LUCERNE","year":2024,"journal":"Ophthalmology","source_url":"https://doi.org/10.1016/j.ophtha.2024.02.014","status":"verified"},{"title":"Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial","year":2024,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(23)02577-1","status":"verified"},{"title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","year":2023,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(23)01520-9","status":"verified"},{"title":"Faricimab Treat-and-Extend for Diabetic Macular Edema","year":2023,"journal":"Ophthalmology","source_url":"https://doi.org/10.1016/j.ophtha.2023.12.026","status":"verified"},{"title":"Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial","year":2023,"journal":"Japanese Journal of Ophthalmology","source_url":"https://doi.org/10.1007/s10384-023-00979-8","status":"verified"}],"source":"works"},"contact":{"address_1":"24075 COMMERCE PARK","city":"Beachwood","state":"OH","zip":"441225846","phone":"216-831-5700","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1780678029","source":"identity"},"similar":[{"name":"Emily Chew","slug":"emily-chew","institution":"National Eye Institute","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/emily-chew","json_url":"https://www.findmykol.com/kol/emily-chew/profile.json"},{"name":"Robert Weinreb","slug":"robert-weinreb","institution":"University of California San Diego","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/robert-weinreb","json_url":"https://www.findmykol.com/kol/robert-weinreb/profile.json"},{"name":"Harry Quigley","slug":"harry-quigley","institution":"Johns Hopkins University School of Medicine","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/harry-quigley","json_url":"https://www.findmykol.com/kol/harry-quigley/profile.json"},{"name":"Joel Schuman","slug":"joel-schuman","institution":"Wills Eye Hospital","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/joel-schuman","json_url":"https://www.findmykol.com/kol/joel-schuman/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":33,"funding":13,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-06-28","provider_certified":"2021-06-28","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}